Breadcrumb Home Yale Technologies NCS1 - A New Target for Mood Disorders and Wolfram Syndrome Yale Lifesciences Pitchfest 2018 12/12/2018 NCS1 - A New Target for Mood Disorders and Wolfram Syndrome Download Pitch Presentation 7_Ehrlich_NCS1+bipolar disease 7May2018 16-9.pdf (19.11 MB) Investigators Barbara Ehrlich, Ph.D. Professor of Pharmacology and of Cellular And Molecular Physiology
